Portal hypertension in a patient with chronic myeloid leukaemia.


A patient with chronic myeloid leukaemia treated with busulphan for 4-5 years, developed signs of busulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice. At post-mortem there was minimal leukaemic infiltration but there were alterations in the liver architecture sufficient to explain the portal hypertension. The… (More)

2 Figures and Tables


  • Presentations referencing similar topics